18 results
DEFA14A
BMY
Bristol-Myers Squibb Co.
10 Apr 23
Additional proxy soliciting materials
5:12pm
& compliance Upholding Board oversight & accountability Governance Experienced & diverse Board Board oversight of strategy & key enterprise risks 64
8-K
EX-99.3
BMY
Bristol-Myers Squibb Co.
29 Apr 22
Bristol Myers Squibb Reports First Quarter Financial Results for 2022
7:42am
100% equitable water use Zero waste to landfill Maintaining highest ethics, integrity & compliance Upholding Board oversight & accountability Promoting … Not for Product Promotional Use Our Commitment as a sustainable organization Embracing environmental stewardship 23 Experienced & diverse Board ― Board
DEFA14A
BMY
Bristol-Myers Squibb Co.
20 Apr 22
Additional proxy soliciting materials
4:30pm
suppliers Concrete Commitments Maintaining highest ethics, integrity & compliance Upholding Board oversight & accountability Governance Experienced … & diverse Board Board oversight of strategy & key enterprise risks 60% female & ethnically diverse directors Shareholder rights Regular shareholder
PX14A6G
nf8zj 3wi9
5 Apr 22
Letter to shareholders
4:53pm
8-K
EX-99.3
h14z8i5
4 Feb 22
Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2021
7:50am
8-K
EX-99.1
9dij3umv7ae85wjqqoy
16 Nov 21
Regulation FD Disclosure
9:20am
PX14A6G
lmmtas e6t
12 Apr 21
Letter to shareholders
5:29pm
PX14A6G
9xiub1
6 Apr 20
Letter to shareholders
6:02am
425
8m92cwwwq 4du4gh
19 Mar 19
Business combination disclosure
7:04am
425
jgt9j fuch7
19 Mar 19
Business combination disclosure
7:02am
425
yxd kkpqurdgqh3
6 Mar 19
Business combination disclosure
7:03am
425
rqrrsud
6 Mar 19
Business combination disclosure
7:00am
- Prev
- 1
- Next